课题基金 / 基金详情

Task E02: Lead Optimization Screening Assays for ADMET

Task E02: Lead Optimization Screening Assays for ADMET
任务 E02：ADMET 的先导化合物优化筛选测定
批准号：
9916128
负责人：
TIMOTHY FENNELL
金额：
$14.05万
依托单位：
RESEARCH TRIANGLE INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
项目状态：
已结题
起止时间：
2019-03-06 至 2020-03-05
来源：
https://reporter.nih.gov/project-details/9916128
关键词：
Antimicrobial ResistanceBiological AssayCandidaChemistryCommunicable DiseasesDNA VirusesDevelopmentDevelopment PlansDrug KineticsEvaluationGram-Negative BacteriaIn VitroInterventional Agent DevelopmentLeadMicrobiologyRNA VirusesSafetyServicesStaphylococcus aureusSupport ContractsTherapeuticToxicologyToxinfungusin vivolead optimizationpathogenpre-clinicalproduct developmentprogramsscreeningtherapeutic development

项目摘要

项目成果

TIMOTHY FENNELL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REPRODUCTIVE ASSESSMENTS BY CONTINUOIUS BREEDING (RACB)
  • 批准号：
    9200931
  • 项目类别：
  • 资助金额：
    $3.11万
  • 财政年份：
    2007
  • 负责人：
    TIMOTHY FENNELL
  • 依托单位：
    RESEARCH TRIANGLE INSTITUTE
海外基金